Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on May 21, 2014. The filing details the results of the company's 2014 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Approximately 89% of the 28,015,938 outstanding shares were represented at the meeting. The following matters were voted upon:
- Election of Class I Directors: Evan Jones and Patrick S. Jones were elected to serve until the 2017 annual meeting.
- Advisory Vote on Executive Compensation: Stockholders approved the compensation of named executive officers for the year ended December 31, 2013. The board determined this vote will occur annually.
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2014, was ratified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirm the company name is Fluidigm Corporation, as the input metadata referenced Standard BioTools Inc.
- Verify the specific vote counts for director elections and executive compensation approval in the full proxy statement.
- Review the company's most recent 10-K or 10-Q for actual financial performance data, as this 8-K contains no financial metrics.
- Note that the advisory vote on executive compensation is now scheduled to occur annually.